In modern practice, one of the most overlooked connections in metabolic health is between fatty liver and heart disease.
Non-Alcoholic Fatty Liver Disease (NAFLD) often develops quietly, without symptoms, yet it significantly increases the risk of cardiovascular complications.
In this article, we will explore how fatty liver and heart disease are closely linked through shared mechanisms such as insulin resistance, inflammation, and dyslipidaemia, and why maintaining liver health is vital for protecting your heart.
What is Fatty Liver? The Overlooked Metabolic Warning Sign
Fatty liver, or NAFLD, occurs when excess fat accumulates in the liver without alcohol as a cause.
It affects up to 30-40% of adults and signals broader metabolic dysfunction, including insulin resistance and chronic inflammation.
Often symptomless, NAFLD acts as an early warning sign of metabolic disease and should never be ignored.
Heart Disease: The Leading Cause of Death in Fatty Liver Patients
In NAFLD patients, cardiovascular disease is the common cause of death. Meta-analyses show a 1.5-fold increased risk of new-onset heart failure and cardiovascular events compared to the general population. This highlights the silent yet deadly partnership between fatty liver and heart disease.
Shared Risk Factors: Insulin Resistance and Inflammation:
NAFLD and heart disease share common metabolic roots such as…..
- Obesity
- Insulin resistance
- Dyslipidaemia
- Hypertension
- Low-grade inflammation.
These overlapping drivers promote both liver fat accumulation and atherosclerosis, forming a cycle that damages the liver and cardiovascular system alike.
The Role of Inflammation: A Silent Trigger for Arterial Damage
Fatty liver triggers the release of inflammatory cytokines and oxidative stress, which damage blood vessels and accelerate plaque formation.
This increases the risk of coronary artery disease and heart attacks. Monitoring and managing inflammation in NAFLD is crucial for long-term cardiovascular protection.
Cholesterol Confusion: How Fatty Liver Alters Lipid Metabolism
NAFLD disrupts how the liver processes fats, leading to raised LDL, VLDL, and triglycerides and reduced HDL levels.
This unfavourable lipid profile contributes to artery hardening and plaque buildup, significantly heightening cardiovascular risk even when other factors appear controlled.
Diagnosing the Danger: Why Screening for One Should Mean Screening for Both
Fatty liver is often detected through imaging or abnormal liver enzymes, but this should prompt cardiac evaluation.
Similarly, patients with heart disease benefit from liver assessment. Identifying both conditions can provide a complete metabolic risk assessment and guide better prevention.
Lifestyle Interventions: One Solution for Two Problems
Lifestyle change is powerful: modest weight loss of 5-10% can reduce liver fat, inflammation, and cholesterol levels.
Adopting a Mediterranean-style diet rich in vegetables, whole grains, and healthy fats, along with regular exercise, improves both liver and heart health.
Beyond the Liver Panel: The Role of Cardiac Testing in NAFLD Management:
For patients with NAFLD, liver assessments should be paired with cardiac evaluations such as……
- Stress testing
- Coronary calcium scoring
- Echocardiography.
Early detection of silent heart disease enables timely treatment and prevents severe complications.
Conclusion
Fatty liver and heart disease form a silent but dangerous duo linked by shared metabolic and inflammatory pathways.
Recognising this connection and addressing both through lifestyle modification and early screening can significantly reduce long-term risk.
Protect your liver and your heart by acting early.
Hema is a Specialist Dietitian at The London Obesity & Endocrine Clinic. She has helped many patients overcome weight management barriers. ©Simplyweight
Top obesity clinic in Chennai
